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Abstract
Background and Purpose—While studies have linked types of fatty acids with coronary heart
disease, data on individual fatty acids and risk of ischemic stroke are limited. We aimed to
examine the associations between serum fatty acid concentrations and incidence of ischemic
stroke and its subtypes.
Methods—We conducted a prospective case-control study nested in the Women's Health
Initiative Observational Study cohort of postmenopausal US women aged 50 to 79 years. Between
1993 and 2003, incident cases of ischemic stroke were matched 1:1 to controls on age, race, and
length of follow-up (964 matched pairs). Conditional logistic regression was used to estimate odds
ratios (OR) and 99.9% confidence intervals (CI) for ischemic stroke and its subtypes.
Results—The multivariable adjusted OR and 99.9% CI of ischemic stroke associated with a 1-
standard deviation (SD) increment in serum fatty acid concentration was 1.38 (99.9% CI,
1.05-1.83) for linelaidic acid (18:2tt, SD=0.04%); 1.27 (99.9% CI, 1.06-1.51) for palmitic acid
(16:0, SD=2.74%); 1.20 (99.9% CI, 1.01-1.43) for oleic acid (18:1n9, SD=2.32%); 0.72 (99.9%
CI, 0.59-0.87) for docosapentaenoic acid (22:5n3, SD=0.18%); 0.72 (99.9% CI, 0.59-0.87) for
docosahexaenoic acid (22:6n3, SD=0.91%); and 0.81 (99.9% CI, 0.67-0.98) for arachidonic acid
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(20:4n6, SD=2.02%). These associations were generally consistent for atherothrombotic and
lacunar stroke, but not cardioembolic stroke.
Conclusions—These findings suggest that individual serum trans, saturated, and
monounsaturated fatty acids are positively associated with particular ischemic stroke subtypes,
while individual n3 and n6 polyunsaturated fatty acids are inversely associated.
Introduction
Few epidemiologic studies have examined the associations between serum fatty acids, a
biomarker of fatty acid intakes, and ischemic stroke risk.1 Thus far, the results have been
inconsistent. One study conducted in Japan found that serum saturated fatty acids were
associated with increased risk of ischemic stroke, while serum linoleic acid (an n6
polyunsaturated fatty acid) was associated with decreased risk.2 Another study conducted in
Finland found similar associations as the Japan study, but additionally reported that serum
monounsaturated and n3 polyunsaturated fatty acids were associated with increased risk of
ischemic stroke.3 However, a third study found no significant associations for serum
saturated or monounsaturated fatty acids.4
Two possibilities have been raised that could explain these inconsistent findings. First, the
associations between serum fatty acids and ischemic stroke may not be consistent for all
ischemic stroke subtypes. In the Japan study described previously, the results were driven by
lacunar stroke, this subtype comprising 95 of the 122 ischemic strokes in that study.2
Importantly, this study did not have sufficient power to examine associations for
atherothrombotic stroke, the subtype of ischemic stroke directly related to blood
cholesterol.5 Combining atherothrombotic stroke with lacunar and cardioembolic strokes
would dilute expected associations. However, to our knowledge, only this Japan study has
examined serum fatty acids in relation to atherothrombotic stroke and other ischemic stroke
subtypes.
Second, the inconsistent findings could be due to individual fatty acids having different
effects on ischemic stroke. In the Japan study described previously, despite finding that
serum myristic and palmitic, but not stearic, saturated fatty acids were positively associated
with total ischemic stroke in unadjusted analysis, investigators combined these three fatty
acids in multivariable analysis.2 Depending on the relative contribution of each fatty acid, it
is possible to find inconsistent associations for total serum saturated fatty acids. However,
few studies have examined serum fatty acids individually while controlling for potential
confounders.
To clarify these possibilities, we conducted a prospective case-control study nested in a
large cohort of postmenopausal US women to examine the associations between 25
individual serum fatty acid concentrations from stored serum samples collected at baseline
and the incidence of ischemic stroke and ischemic stroke subtypes. We hypothesize that
individual serum trans and saturated fatty acids would be positively associated with
atherothrombotic stroke, whereas individual serum monounsaturated and polyunsaturated
fatty acids would be inversely associated.
Methods
Study Population
We conducted a case-control study of 964 incident ischemic stroke cases and 964 matched
control subjects nested within the Women's Health Initiative Observational Study (WHI-
OS).6 Briefly, the WHI was conducted in 40 clinical centers across the US to examine the
impact of a number of factors on the major causes of morbidity and mortality in
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postmenopausal women.7 Eligible women were 50 to 79 years of age at baseline,
postmenopausal, had no medical conditions associated with a predicted survival of <3 years,
and provided informed consent to be a part of the study as approved by the institutional
review boards. The WHI-OS enrolled 93,676 women between October 1993 and December
1998. There were 972 confirmed incident ischemic stroke cases between 1993 and 2003.
Control subjects were individually matched 1:1 to the cases on age and race at the time of
ischemic stroke. Blood quantity was not sufficient to analyze fatty acid content for 9
participants, leaving a total of 964 case-control pairs.
Case identification and classification
Incident ischemic strokes during the follow-up period were identified through self-report
during annual medical history updates (annual response rate 94%).8 Using additional details
from medical charts, brain imaging, or death certificates, the potential outcomes were
subject to local adjudication by physicians, then central adjudication by trained neurologists,
according to standard criteria. Over 95% of participant-reported stroke cases were classified
based on CT or MRI findings.9
Central adjudicators further classified ischemic strokes by subtypes according to the Trial of
ORG 10172 Acute Stroke Trial (TOAST) Classification.10 The TOAST classification
focuses on the presumed underlying stroke mechanism; requires detailed investigations
(such as brain computed tomography, magnetic resonance imaging, angiography, carotid
ultrasound, and echocardiography); and distinguishes 5 categories of stroke, which include
large artery atherothrombotic stroke, small vessel lacunar stroke, cardioembolic stroke,
other, and undetermined mechanism.11 Probable and possible subtypes determinations were
combined in this report. Transient ischemic attack, hemorrhagic stroke, strokes not requiring
hospitalization, and strokes not confirmed by central adjudication were not included as a
stroke outcome.
Control selection
Controls were sampled from women at risk at the time ischemic stroke events occurred
during the follow-up period and matched 1:1 to case subjects on age at baseline (±2 years),
race/ethnicity (white, black, Hispanic, Asian, American Indian, or other/unspecified), date of
study enrollment (±3 months), and follow-up time.
Data collection
Fasting blood samples were collected from all WHI-OS participants by clinic staff members
following a standardized protocol for venipuncture at baseline.12 Samples were centrifuged,
separated by layers, frozen onsite at −70°C, and shipped to the central WHI repository for
long-term storage.
Serum fatty acids were analyzed at Dr. Rhobert Evans' lab at the University of Pittsburgh.
Fatty acids were extracted according to the general technique of Bligh and Dyer using 1, 2-
dinonadecanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids, Inc. Alabaster, AL) (50
μg of 19:0) as an internal standard.13 The lipid extracts were resuspended in 1.5 ml 14%
boron trifluoride methanol and derivatized according to the procedure of Morrison and
Smith.14 The extracts were analyzed by capillary GC:column (SP-2380, 105 m × 53 mm ID,
0.20 um film thickness). The gas chromatograph was a Perkin Elmer Clarus 500 equipped
with a flame ionization detector. Operating conditions: the oven temperature was 140°C for
35 min, then ramped at 8°C/min to 220°C, and held for 12 min. Injector and detector
temperatures were both at 260°C and helium, the carrier gas, was at 15 psi. Identification of
components was by comparison of retention times with those of authentic standards (Sigma
Chemical Co., St. Louis, MO). Duplicate samples and control pools were analyzed with
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each batch of samples. The coefficients of variation of fatty acids ranged from 3.1% to
13.2%. The Spearman correlation coefficients between dietary fatty acid intake (% of total
fat intake assessed by a FFQ) and serum fatty acid concentrations among non-cases (both
measured at baseline) were 0.53 for docosahexaenoic acid (DHA), 0.42 for eicosapentaenoic
acid (EPA), 0.18 for docosapentaenoic acid (DPA), 0.16 for palmitic acid, 0.15 for linelaidic
acid, 0.07 for arachidonic acid, and 0.03 for oleic acid.
Participants completed sociodemographic and lifestyle questionnaires during baseline visits
to a WHI clinical center.12 Physical activity was assessed based on participant report about
the frequency, intensity, and duration of walking, exercise, or recreational activity and
summarized into total metabolic equivalent task (MET)-hours per week. Certified clinic
staff measured participant height, weight, and blood pressure. Height and weight were
measured without shoes or heavy clothing and with pocket contents removed. Body mass
index (BMI) was calculated by dividing weight in kilograms by the square of height in
meters. Following standardized procedures, blood pressure was measured twice after a 5-
minute seated rest with a 30-second rest in between. The average of two blood pressure
measurements was used in analysis. Hypertension was defined as systolic blood pressure ≥
140 mm Hg or a diastolic blood pressure ≥ 90 mm Hg or self-report of antihypertensive
medication use. Diabetes was defined as being on treatment for diabetes by self-report or
having a fasting glucose level ≥ 126 mg/dL. Participants reported their history of smoking,
diabetes, atrial fibrillation, angina, or revascularization (coronary bypass surgery or
angioplasty of the coronary arteries), as well as current use of medications.
Lipoprotein profiles were assayed at Liposcience using nuclear magnetic resonance. Low-
density lipoprotein (LDL) cholesterol was calculated from high-density lipoprotein (HDL)
cholesterol, total cholesterol, and triglyceride concentrations among women who had a
triglyceride value <400 mg/dL using the Friedewald equation.15 LDL cholesterol values
were set to missing for those women whose triglyceride value was >400 mg/dL (n=35) or
who were missing HDL cholesterol, total cholesterol, or triglyceride values (n=7).
Statistical analysis
The McNemar's chi-square test was used to compare covariate proportions between
ischemic stroke cases and controls. The Wilcoxon signed-rank test was used to compare
serum fatty acid concentration and covariate means between ischemic stroke cases and
controls. The distributions of the serum fatty acids were highly skewed to the right.
Therefore, we used the median as the measure of central tendency for descriptive statistics.
Conditional logistic regression was used to estimate odds ratios (OR) and 99.9% confidence
intervals (CI) for ischemic stroke and its subtypes, conditioning on matching factors in all
models. We divided women into quintiles based on distribution of serum fatty acid
concentrations in the case-control study population. We estimated multivariable adjusted
ORs and 99.9% CIs comparing the odds of ischemic stroke among women in the higher
quintiles of serum fatty acids with the odds of ischemic stroke in the lowest quintile. Linear
trend tests were performed by assigning the median value of the quintile of the fatty acid to
each category and entering this variable into the model as a continuous variable. Since
trends were generally linear, multivariable adjusted ORs were calculated per 1-standard
deviation (SD) increment in each fatty acid. Our primary model was adjusted for BMI,
smoking status, diabetes, and aspirin use. Subsequent models were adjusted for blood
pressure and blood cholesterol variables, since these factors are the likely mediators of the
association between serum fatty acids and ischemic stroke. Two-sided P ≤ 0.001 was
considered significant to account for multiple comparisons and to decrease the risk of
detecting a false positive association (Type I error). All analyses were performed using SAS
statistical software (Version 9.2, SAS Institute Inc., Cary, NC, USA).
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Between 1993 and 2003, we identified 964 cases of incident ischemic stroke. Of these, 96
were atherothrombotic strokes, 250 were lacunar strokes, 209 were cardioembolic strokes,
42 were ischemic strokes of other determined etiology, 366 were ischemic strokes of
undetermined etiology, and 1 was missing subtype information. The mean age at baseline of
women with ischemic stroke was 68.7 (SD 6.4) years (Table 1). Women with incident
ischemic stroke were more likely to be overweight or obese, be a current smoker, have
diabetes, and to use aspirin. We accounted for these differences by adjusting for these
variables in multivariable adjusted analysis.
Distribution of serum fatty acids
Twenty-five individual serum fatty acids were examined (Table 2). The major contributors
(median >5%) to the composition of serum fatty acids were linoleic (27%), palmitic (24%),
oleic (18%), stearic (9%), and arachidonic (8%) fatty acids. The serum concentrations of
18:1t and linelaidic trans fatty acids, myristic and palmitic saturated fatty acids, and 7-
hexadecenoic, oleic, and eicosenoic monounsaturated fatty acids were higher among
ischemic stroke cases than controls. The concentrations of alpha-linolenic, eicosatetraenoic,
EPA, DPA, DHA n3 polyunsaturated fatty acids and linoleic, arachidonic, adrenic, and
22:5n6 n6 polyunsaturated fatty acids were lower among ischemic stroke cases than
controls.
Total ischemic stroke
With adjustment for BMI status, smoking status, diabetes, and aspirin use and accounting
for the matching factors, serum linelaidic acid (18:2tt, SD=0.04%, OR=1.38, 99.9%CI,
1.05-1.83), palmitic acid (16:0, SD=2.74%, OR=1.27, 99.9%CI, 1.06-1.51), and oleic acid
(18:1n9, SD=2.32%, OR=1.20, 99.9%CI, 1.01-1.43) were associated with increased
incidence of ischemic stroke. Serum DPA (22:5n3, SD=0.18%, OR=0.72, 99.9%CI,
0.59-0.87), DHA (22:6n3, SD=0.91%, OR=0.72, 99.9%CI, 0.59-0.87) and arachidonic acid
(20:4n6, SD=2.02%, OR=0.81, 99.9%CI, 0.67-0.98) were associated with decreased
incidence (Figure 1, eTable 1). Further adjustment for blood pressure and blood cholesterol
did not change estimates by more than 10%.Neither did further adjustment for physical
activity, angina, atrial fibrillation, or revascularization change estimates by more than 10%
(data not shown).
To examine the possibility that the positive association for serum oleic acid was due to its
correlations with serum arachidonic acid or serum DHA (Spearman rank correlation
coefficients -0.43 and -0.31, respectively), we additionally adjusted for these fatty acids
using the residual method.16 The multivariable adjusted OR for total ischemic stroke
associated with a 1-SD increment in oleic acid was attenuated by 9% after adjustment for
serum arachidonic acid, by 10% after adjustment for serum DHA, and completely attenuated
after adjustment for serum total polyunsaturated fatty acids (OR=1.00, 99.9% CI, 0.84-1.19).
Ischemic stroke subtypes
We further examined the fatty acids that were significantly associated with total ischemic
stroke (serum linelaidic acid, palmitic acid, oleic acid, DPA, DHA, and arachidonic acid) in
relation to ischemic stroke subtypes. The associations between these serum fatty acids and
total ischemic stroke were generally consistent for atherothrombotic stroke, lacunar stroke,
and ischemic stroke of undetermined etiology, except that we did not observe a positive
association between palmitic acid and atherothrombotic stroke (Figure 2, eTable 2).We did
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observe an inverse association between serum DHA and cardioembolic stroke, making DHA
the only serum fatty acid to be consistently inversely associated with all subtypes of
ischemic stroke. We did not have sufficient statistical power to examine associations for
ischemic strokes of other determined etiology (42 matched pairs).
Further adjustment for blood pressure attenuated associations for lacunar stroke (e.g., by
10% for DHA), but not atherothrombotic stroke. Further adjustment for blood cholesterol
attenuated associations for lacunar stroke (e.g., by 37% for linelaidic fatty acid) and
atherothrombotic stroke (e.g., by 82% for linelaidic fatty acid, and reversed the associations
for palmitic and oleic fatty acids).
Discussion
In this study, the largest case-control study of ischemic strokes among postmenopausal US
women, serum linelaidic (trans) acid, palmitic (saturated) acid, and oleic (monounsaturated)
acid were associated with increased incidence of ischemic stroke. Serum DPA, and DHA
(n3 polyunsaturated) acids and arachidonic (n6 polyunsaturated) acid were associated with
decreased incidence. These associations were generally consistent for atherothrombotic and
lacunar stroke, but not cardioembolic stroke.
Our results suggest that individual serum fatty acids have different associations with
ischemic stroke. However, large prospective cohort studies have not been able to examine
fatty acids individually. These studies assessed fatty acid intake through participant report of
diet (e.g. FFQ), which can only distinguish major types of fat (e.g., saturated fat). Two
prospective studies reported that saturated fat intake and animal fat intake (mostly saturated
fat) were associated with decreased risk of ischemic stroke and cerebral infarction death,
respectively.17, 18 However, four prospective studies failed to find associations between
saturated fat intake and ischemic stroke.19-22 One possible explanation for these inconsistent
results is that individual fatty acids, even those of the same type, may have different effects
on cardiovascular disease risk. For example, myristic (14:0) and palmitic (16:0) acids tend to
increase plasma total and LDL-cholesterol concentrations compared with oleic acid, whereas
stearic acid (18:0) does not.23 It is possible that examining general types of fat intake
masked the associations of individual fatty acids and ischemic stroke. However, individual
fatty acids used in studies of dietary intake tend to be highly correlated. These high
correlations make distinguishing their individual relations with ischemic stroke risk
difficult.24
In contrast to the prospective studies using fatty acids intake derived from participant report
of intake, case-control studies using biomarkers of fatty acid intake – serum, erythrocytes,
and adipose tissue – are able to examine fatty acids individually (e.g., palmitic acid). In the
largest of these previous studies, Iso and colleagues found that serum myristic and palmitic
acids, but not stearic acid, were associated with increased risk of ischemic stroke, even
though all three are saturated fatty acids.2 In addition, serum linoleic acid, but not other
polyunsaturated fatty acids, was associated with decreased risk of ischemic stroke. Smaller
case-control studies also suggest that individual fatty acids, even those of the same type,
may have different effects on ischemic stroke risk.4, 25-27 These studies highlight the
importance of examining individual fatty acids in relation to ischemic stroke risk.
Our results also suggest that the associations between serum fatty acids and ischemic stroke
may not be consistent across all ischemic stroke subtypes. To our knowledge, only two
studies have reported associations for ischemic stroke subtypes. In these studies, the
associations between individual fatty acids and total ischemic stroke were consistent for
lacunar stroke, but not atherothrombotic or cardioembolic stroke. Iso and colleagues
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reported that the associations between serum saturated and linoleic fatty acids and ischemic
stroke were driven by lacunar stroke, this subtype comprising 95 of the 122 ischemic strokes
in that study.2 In a recent longitudinal study using data from the full WHI-OS cohort, we
found that the positive association between dietary trans fat intake and ischemic stroke was
consistent for lacunar stroke, but in that study, we were not able to examine the associations
for individual fatty acids and the statistic power was insufficient for examining
atherothrombotic strokes.22 Nevertheless, these prior studies highlight the importance of
examining ischemic stroke subtypes separately.
The associations between fatty acids and ischemic stroke may not be consistent across all
subtypes because ischemic stroke is a heterogeneous condition. There is evidence that blood
cholesterol may play a role in the development of some ischemic stroke subtypes, but not
others.5 Kuller and Reisler examined the incidence of ischemic stroke subtypes in
populations with varying blood cholesterol levels.28 Based on this analysis, they
hypothesized that blood cholesterol may play a role in atherothrombotic stroke, the ischemic
stroke subtype with an atherogenic basis. Fatty acid intakes have a powerful effect on blood
cholesterol concentrations, and they were hypothesized to play a role in the development of
atherothrombotic stroke, as well. One of the challenges in studying atherothrombotic stroke,
the least prevalent ischemic stroke subtype, is low statistical power. However, we had
sufficient power to detect general trends in atherothrombotic stroke incidence according to
serum fatty acid concentration. Consistent with Kuller and Reisler's hypothesis, linelaidic,
oleic, DPA, DHA, and arachidonic acids were associated with atherothrombotic stroke.
While the effect of fatty acid intake on blood cholesterol likely explains the associations for
atherothrombotic stroke, the explanation for the apparent associations for lacunar stroke is
not clear. However, a few possibilities can be proposed. First, intake of DHA may lower
blood pressure. A meta-analysis of 36 randomized trials reported that fish oil
supplementation lowered systolic and diastolic blood pressures by 3.5 and 2.4 mm Hg,
respectively.29 Importantly, serum DHA, which may have a stronger blood pressure
lowering effect than EPA,30 was the only serum fatty acid that was consistently associated
with all subtypes of ischemic stroke in the present study. Second, intake of DHA inhibits
thrombosis through their anti-platelet effects.31 In the present study, serum DHA was
inversely correlated with d-dimer concentration, which is a measure of thrombotic disease
such as lacunar stroke. Third, intake of trans fat and n3 polyunsaturated fatty acids have pro-
and anti-inflammatory effects, respectively.32, 33 High concentrations of inflammatory
markers have been associated with greater neurological deterioration in lacunar strokes.34
Finally, there is limited evidence suggesting that trans fat intake may adversely affect
glucose tolerance, which may lead to development of diabetes, which is a major risk factor
for lacunar stroke. Most observational studies report a positive association between trans fat
intake and diabetes, however these results have not been supported by the results of
controlled feeding studies.35
Our study has some limitations. One concern is the stability of serum fatty acids during
storage and freeze/thaw procedures. However, serum storage for up to 12 years at −80°C
protected polyunsaturated fatty acids, the most susceptible fatty acids to storage and freeze-
thaw, from oxidation.36 We conducted an analysis of 15 samples analyzed originally in
2005, one year later in 2006, and then after an additional freeze/thaw procedure. No
statistically significant differences were detected between the mean values of the fatty acids
from the original and one-year or freeze/thaw samples. In addition, serum fatty acids may
reflect diet only over a short period of time, and only one measure of serum was done in the
WHI. We make the assumption that the concentration of fatty acids in serum remains
relatively stable over time.
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When these ischemic strokes were classified, TOAST was the best currently available with
moderate to good inter-observer reliability with training11. The field of ischemic stroke
classification has been evolving to address the large number of cases that are classified as
having “undetermined etiology.” In the newer ASCO Phenotypic System, cases can be
characterized by all 4 phenotypes based on the level of diagnostic certainty37. Using the
ASCO classification could reduce the proportion of ischemic stroke cases with
underdetermined etiology and increase statistical power.
Another concern is that the TOAST classification uses a history of diabetes mellitus and
hypertension in its lacunar stroke definition.38 This classification bias could, in part, explain
the association between serum fatty acid and lacunar stroke, assuming that serum fatty acids
act through hypertension to increase risk of ischemic stroke. More recent studies have
advocated the use of a “risk factor-free classification” to avoid classification bias.5
However, the prevalence of hypertension among the ischemic stroke subtypes was relatively
uniform (72% of atherothrombotic, 73% of lacunar, and 68% of cardioembolic stroke cases)
suggesting that this misclassification was not a major source of bias in this study.
Finally, there is evidence that associations between fatty acid biomarkers and ischemic
stroke may vary by the age of the study population and type of biomarker used.3 The results
derived from this study population of predominately white postmenopausal women may not
be generalizable to other populations.
In conclusion, we report that serum linolaidic trans fatty acid, palmitic saturated fatty acid,
and oleic monounsaturated fatty acid were positively associated with incidence of ischemic
stroke, while serum DPA and DHA n3 polyunsaturated fatty acids and arachidonic n6
polyunsaturated fatty acid were inversely associated with incidence of ischemic stroke.
These associations were generally consistent for atherothrombotic and lacunar strokes.
These findings highlight the importance of individual fatty acids in the development of
particular subtypes of ischemic stroke.
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Table 1
Baseline characteristics of the study population by ischemic stroke case and control status.
Non-case Case
N 964 964
Age, year 68.7 (6.4) 68.7 (6.4)
Race
 African American 79 (8) 79 (8)
 Native American 5 (1) 5 (1)
 Asian 21 (2) 21 (2)
 Hispanic 20 (2) 20 (2)
 White 826 (86) 826 (86)
 Other 10 (1) 10 (1)
Education
 ≤ High school/GED 226 (24) 235 (25)
 Some college/ training after high school 358 (37) 391 (41)
 College graduate 377 (39) 330 (35)
Family income
 <$35,000 427 (48) 479 (54)
 $35,000 to $74,999 332 (38) 302 (34)
 ≥$75,000 126 (14) 114 (13)
Moderate/strenuous activities ≥20 minutes*
 None 121 (13) 149 (16)
 Some 356 (37) 419 (44)
 2-4 episodes/wk 198 (21) 160 (17)
 >4 episodes/wk 282 (29) 225 (24)
Alcohol intake
 Non-drinker 111 (12) 117 (12)
 Past drinker 177 (18) 211 (22)
 <7 drinks/wk 559 (58) 511 (53)
 ≥7 drinks/wk 116 (12) 122 (13)
Blood pressure, mm Hg
 Systolic* 130 (18) 137 (20)
 Diastolic* 74 (10) 75 (10)
Hypertensiona* 450 (47) 647 (67)
Serum lipids, mg/dL
 Total cholesterol 231 (38) 233 (39)
 HDL-C* 60 (16) 57 (16)
 LDL-C 139 (37) 141 (37)
 Triglycerides* 161 (80) 180 (90)
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Non-case Case
 Total cholesterol to HDL-C ratio* 4.2 (1.4) 4.4 (1.5)
BMI, kg/m2*
 Mean 27.0 (5.3) 27.7 (5.9)
 < 25.0 388 (41) 330 (35)
 25.0 to 29.9 342 (36) 365 (38)
 ≥30.0 221 (23) 260 (27)
Smoking status*
 Never 523 (55) 501 (53)
 Past 397 (42) 374 (39)
 Current 36 (4) 78 (8)
Comorbidities
 Diabetesb* 72 (7) 153 (16)
 Atrial fibrillation* 55 (6) 92 (10)
 Angina* 53 (6) 90 (9)
 Revascularization* 11 (1) 38 (4)
Medications
 Aspirin* 238 (25) 295 (31)
 Antihypertensive* 319 (33) 449 (47)
 Lipid-lowering 157 (16) 182 (19)
 Statins 83 (9) 92 (10)
 HRT 363 (38) 381 (40)
GED, General Equivalency Diploma; BMI, body mass index; HRT, hormone replacement therapy
*
McNemar's chi-square or paired Student's t test P ≤ 0.05, as appropriate.
a
Hypertension was defined as systolic blood pressure ≥ 140 mm Hg or a diastolic blood pressure ≥ 90 mm Hg or self-report of antihypertensive
medication use.
b
Diabetes was defined as having a fasting glucose level ≥ 126 mg/dL or being on treatment for diabetes by self-report.
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